-
Highlights from last weeks webinar
Webinar Recap: Advancements in Prostate Cancer Treatment Last week, we hosted our annual webinar in collaboration with our dedicated users, focusing on optimizing SBRT and strategies to reduce side effects […]
·
-
New research: Five treatment sessions as effective as 39 for radiation therapy in prostate cancer
New research: Five treatment sessions as effective as 39 for radiation therapy in prostate cancer In mid-October, results were published from a British long-term follow-up study of 874 prostate cancer […]
-
First Raypilot System Order in the U.S
Micropos Medical AB announced that the company has received an order through its U.S. subsidiary, Micropos Medical Inc., to deliver a Raypilot® system to the Medical University of South Carolina […]
-
New article from Edinburg Cancer Centre shows positive patient outcomes in preliminary study
The team in Edinburgh at Edinburg Cancer Centre has just published a new article regarding their work with the old Raypilot device and also with the Raypilot catheter solution. The […]
·
-
Groundbreaking research shows single-dose radiotherapy has very low side effects despite high doses
New research published in Red Journal shows that single-dose radiotherapy, enhanced by motion control and the Raypilot System, can deliver high doses with very low side effects. The study demonstrates this approach significantly improves patients’ quality of life by minimizing toxicity.
-
Presentations from ESTRO2024 Seminars Now Available
We are pleased to share that the presentations from our recent scientific seminars at ESTRO2024 are now accessible on our website at the Media Section or to download in this news post.
·
-
Årsredovisning 2023
Välkommen att ladda ner Årsredovisning 2023. Du hittar den genom att klicka på nyheten eller på vår Investor sida under Rapporter.
-
KALLELSE TILL ÅRSSTÄMMA I MICROPOS MEDICAL AB (PUBL)
Aktieägarna i Micropos Medical AB (publ), 556648-2310, kallas härmed till årsstämma onsdagen den 29 maj 2024 kl. 16.30, på Konferenslokal Pråmen, Göteborg, Adolf Edelsvärds Gata 11, Göteborg.
-
Emissionsmemorandum 2024
Göteborg, 2024-02-19 Välkommen att ladda ner Emissionsmemorandum 2024. Du hittar den genom att klicka på nyheten eller på vår Investor sida under Rapporter.
-
Micropos Medicals VD Thomas Lindström blickar tillbaka på några av höjdpunkterna under året som gått
Pressmeddelande publicerat Onsdagen den 20:e December, 2023 Antalet behandlade patienter med Raypilot System ökarTotalt har 250 patienter behandlats med Raypilot sedan starten. Det är ett bra underlag.Under året har de […]
